Cargando…

Serotonin reuptake inhibitors and bleeding risks related to elderly submitted to major orthopedic surgery

Detalles Bibliográficos
Autor principal:	Savioli, Felicio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Israelita de Ensino e Pesquisa Albert Einstein 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777648/ https://www.ncbi.nlm.nih.gov/pubmed/31618290 http://dx.doi.org/10.31744/einstein_journal/2019ED5214

Ejemplares similares

Serotonin reuptake inhibitors and post-gastrostomy bleeding: reevaluating the link
por: Patel, Harish, et al.
Publicado: (2015)

The use of serotonin reuptake inhibitors increases the risk of bleeding in patients with assist devices
por: Auschra, Bianca, et al.
Publicado: (2022)

Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression
por: James, Gregory M., et al.
Publicado: (2017)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)

Selective Serotonin Reuptake Inhibitors and Gastrointestinal Bleeding: A Case-Control Study
por: Carvajal, Alfonso, et al.
Publicado: (2011)

Selective Serotonin Reuptake Inhibitor Use and Risk of Major Bleeding during Treatment with Vitamin K Antagonists: Results of A Cohort Study
por: Bakker, Sanne, et al.
Publicado: (2022)

Upper gastrointestinal bleeding in a patient with depression receiving selective serotonin reuptake inhibitor therapy
por: Kumar, Deepak, et al.
Publicado: (2009)

Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
por: Welsch, Patrick, et al.
Publicado: (2018)

Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019)

Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment During Hepatic Surgery
por: Starlinger, Patrick, et al.
Publicado: (2021)

Gastrointestinal bleeding risk of selective serotonin reuptake inhibitors by level of kidney function: A population‐based cohort study
por: Iwagami, Masao, et al.
Publicado: (2018)

Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial
por: Quinn, Gene R., et al.
Publicado: (2018)

Effect of Serotonin Reuptake Inhibitors on Pulmonary Hemodynamics in Humans
por: Pleym, Hilde, et al.
Publicado: (2011)

Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis
por: Wozniak, Greta, et al.
Publicado: (2011)

Heart Rate Recovery and Selective Serotonin Reuptake Inhibitors
por: Cerit, Levent
Publicado: (2016)

Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia
por: Bhattacharjee, Subir, et al.
Publicado: (2021)

Confounding by Indication in Studies of Selective Serotonin Reuptake Inhibitors
por: Lee, Jimin, et al.
Publicado: (2022)

Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
por: Takata, Junko, et al.
Publicado: (2019)

Does serotonin reuptake inhibitor therapy increase the risk of post-sphincterotomy bleeding in patients undergoing endoscopic retrograde cholangio-pancreatography?
por: Yadav, Divya, et al.
Publicado: (2017)

Bleeding risk between newer direct-acting oral anticoagulants and selective serotonin reuptake inhibitors. Case report and literature review
por: Higueras, T. Gutiérrez, et al.
Publicado: (2021)

Salivary cortisol in women with major depressive disorder under selective serotonin reuptake inhibitors therapy
por: Dziurkowska, Ewelina, et al.
Publicado: (2013)

Effects of selective serotonin reuptake inhibitor treatment on plasma oxytocin and cortisol in major depressive disorder
por: Keating, Charlotte, et al.
Publicado: (2013)

Structural Requirements for Modulating 4-Benzylpiperidine Carboxamides from Serotonin/Norepinephrine Reuptake Inhibitors to Triple Reuptake Inhibitors
por: Paudel, Suresh, et al.
Publicado: (2021)

Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis
por: Gosmann, Natan Pereira, et al.
Publicado: (2021)

The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials
por: Azizi, Marzieh, et al.
Publicado: (2022)

Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors
por: Cosci, Fiammetta, et al.
Publicado: (2022)

Dual Roles for the TSPYL Family in Mediating Serotonin Transport and the Metabolism of Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder
por: Qin, Sisi, et al.
Publicado: (2019)

Transient Serotonin Syndrome Caused by Concurrent Use of Tramadol and Selective Serotonin Reuptake Inhibitor
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2014)

Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk
por: Srivastava, Ankit, et al.
Publicado: (2019)

Candidate genes for antidepressant response to selective serotonin reuptake inhibitors
por: Lotrich, Francis E, et al.
Publicado: (2005)

Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
por: Briley, Mike, et al.
Publicado: (2010)

Prenatal exposure to serotonin reuptake inhibitors: a case report
por: Marsella, Maria, et al.
Publicado: (2010)

Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise
por: Marks, David M, et al.
Publicado: (2009)

Bioimpedance in monitoring of effects of selective serotonin reuptake inhibitor treatment
por: Alexeev, Vasiliy Grigorievich, et al.
Publicado: (2011)

Hyperprolactinemia and breast enlargement with serotonin reuptake inhibitor and olanzapine combination
por: Praharaj, Samir Kumar
Publicado: (2011)

Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
por: Diav-Citrin, Orna, et al.
Publicado: (2012)

Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine
por: Kobayashi, Katsunori, et al.
Publicado: (2011)

Enhanced Responsiveness to Selective Serotonin Reuptake Inhibitors during Lactation
por: Jury, Nicholas J., et al.
Publicado: (2015)

Serotonin and Noradrenaline Reuptake Inhibitors Improve Micturition Control in Mice
por: Redaelli, Marco, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sb6nr8ti23nbs8321poqfggq3h